Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PTC Therapeutics
PTC Therapeutics
Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song
Endpoints
Thu, 05/7/20 - 10:42 am
PTC Therapeutics
Censa Pharmaceuticals
PKU
M&A
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Reuters
Wed, 11/27/19 - 12:36 pm
gene therapy
drug manufacturing
Pfizer
Novartis
Bluebird Bio
PTC Therapeutics
Krystal Biotech
Roche, PTC will now get an FDA decision on their SMA drug in 6 months — facing off with Biogen, Novartis
Endpoints
Mon, 11/25/19 - 09:52 am
Roche
PTC Therapeutics
SMA
risdiplam
Biogen
Spinraza
What could help biotech close out 2019 stronger? Analysts pick 3 events to watch
Biopharma Dive
Sat, 09/7/19 - 06:38 pm
Amgen
AMG 510
KRAS inhibitors
Roche
PTC Therapeutics
risdiplam
Eylea
Novartis
Roche, PTC post latest SMA data from their attempt to rival Spinraza, Zolgensma
Fierce Biotech
Tue, 05/7/19 - 10:19 am
Roche
PTC Therapeutics
spinal muscular atrophy
risdiplam
Novartis
Zolgensma
Biogen
Spinraza
Nabbing late-stage drug, PTC acquires gene therapy startup Agilis for $200M in cash/stock
Endpoints
Thu, 07/19/18 - 11:23 pm
PTC Therapeutics
gene therapy
M&A
Agilis
Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday
Motley Fool
Tue, 06/19/18 - 10:42 pm
PTC Therapeutics
risdiplam
Biogen
Ionis Pharmaceuticals
spinal muscular atrophy
Sarepta Therapeutics
Translarna
Emflaza
Did the FDA just leave the door cracked open for PTC’s Duchenne drug after repeated slapdowns?
Endpoints
Tue, 02/20/18 - 09:17 am
FDA
PTC Therapeutics
DMD
Duchenne Muscular Dystrophy
ataluren
The Winners And Losers Of JP Morgan Monday
Forbes
Mon, 01/8/18 - 10:23 pm
JPMHC 2018
Cellular Biomedicine
Alder Biopharmaceuticals
Nevro
Insulet
PTC Therapeutics
Axovant Sciences
Momenta
Natus Medical
Oxford Immunotec
EXACT Sciences
No Charm: PTC’s Duchenne Drug Rejected by FDA for Third Time
Xconomy
Thu, 10/26/17 - 09:25 am
PTC Therapeutics
Duchenne Muscular Dystrophy
FDA
Translarna
FDA experts turn thumbs down on PTC’s wobbly case for its Duchenne MD drug
Endpoints
Fri, 09/29/17 - 09:42 am
FDA
PTC Therapeutics
Duchenne Muscular Dystrophy
ataluren
FDA pours cold water on PTC Therapeutics' Duchenne application
Reuters
Wed, 09/27/17 - 10:02 am
FDA
PTC Therapeutics
Duchenne Muscular Dystrophy
ataluren
Duchenne muscular dystrophy
Motley Fool
Thu, 09/21/17 - 10:10 pm
Duchenne Muscular Dystrophy
PTC Therapeutics
Translarna
Axovant Sciences
Alzheimer's disease
NASH
Gilead Sciences
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
FDA
Mylan Labs
Herceptin
biosimilars
trastuzumab
Shingrix
GSK
Pfizer
Sutent
PTC Therapeutics
Translarna
Amgen
Allergan
Avastin
3 Biotech Stocks That Could Soar in September
Motley Fool
Sun, 08/27/17 - 06:26 pm
biotech
fitusiran
Alnylam
PTC Therapeutics
Translarna
Sarepta
Exondys 51
PTC and Roche report solid data for Spinraza rival
BioPharma Dive
Wed, 07/5/17 - 06:55 pm
PTC Therapeutics
Roche
Spinraza
Biogen
RG7916
SMA
spinal muscular atrophy
PTC to launch DMD drug with still high price tag
BioPharma Dive
Wed, 05/10/17 - 09:47 am
PTC Therapeutics
drug pricing
Duchenne Muscular Dystrophy
Emflaza
Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch
Fierce Pharma
Sat, 04/15/17 - 09:27 am
PTC Therapeutics
Emflaza
drug launches
drug pricing
Duchenne Muscular Dystrophy
PTC comes under fire from Congress for Emflaza
BioPharma Dive
Wed, 03/22/17 - 10:39 pm
PTC Therapeutics
Emflaza
drug pricing
congress
After being spurned at the FDA, PTC buys a controversial Duchenne MD therapy from Marathon
Endpoints
Thu, 03/16/17 - 09:48 am
FDA
PTC Therapeutics
Duchenne Muscular Dystrophy
Emflaza
Marathon Pharma
Pages
« first
‹ previous
1
2
3
4
next ›
last »